GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » EPS without NRI

Lobe Sciences (Lobe Sciences) EPS without NRI : $-0.02 (TTM As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences EPS without NRI?

Lobe Sciences's earnings per share without non-recurring items for the three months ended in Feb. 2024 was $-0.01. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Lobe Sciences's EPS without NRI or its related term are showing as below:

LOBEF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72.4   Med: 17.85   Max: 53.6
Current: 41.6

LOBEF's 3-Year EPS without NRI Growth Rate is ranked better than
87.06% of 1298 companies
in the Biotechnology industry
Industry Median: 5.15 vs LOBEF: 41.60

Lobe Sciences's EPS (Diluted) for the three months ended in Feb. 2024 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.01.

Lobe Sciences's EPS (Basic) for the three months ended in Feb. 2024 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.01.


Lobe Sciences EPS without NRI Historical Data

The historical data trend for Lobe Sciences's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences EPS without NRI Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -0.17 0.31 -0.09 -0.03

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 - -0.01 -0.01

Competitive Comparison of Lobe Sciences's EPS without NRI

For the Biotechnology subindustry, Lobe Sciences's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's PE Ratio without NRI falls into.



Lobe Sciences EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lobe Sciences  (OTCPK:LOBEF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Lobe Sciences EPS without NRI Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (Lobe Sciences) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.